w26052102 imbokodo & mosaico updates, plans for correlates and sieve analyses.
Published 3 years ago • 268 plays • Length 10:54Download video MP4
Download video MP3
Similar videos
-
2:52
w26052100 workshop introduction
-
23:37
w26052107 gene signature associating with hiv vaccine efficacy and antibody effector function
-
14:02
w26052105 innate immune analyses
-
58:40
ve-panel 2c: research pathway for the use of monoclonal antibodies in hiv prevention.
-
3:19
the battle for affordable access to a 100% effective hiv drug lenacapavir or sunlenca
-
4:21
an hiv vaccine is coming
-
7:22
new hiv vaccine! 'mosaico'
-
16:35
w26052106 discovering correlates of risk in absence of overall protection to inform vaccine design
-
56:51
ve-panel 2b: future design approaches for hiv vaccine efficacy trials
-
5:41
w26052108 workshop final remarks.
-
1:29:06
webinar 02 – experimental medicine trials for hiv research
-
28:50
s3-04: evaluating an hiv vaccine efficacy vs. counterfactual placebo: immune mediator approach
-
15:03
update on hiv vaccine and monoclonal antibody | glenda e. gray, mbbch, fcpaeds (sa), dsc
-
5:36
aids 2022- a conversation with assistant secretary for global affairs loyce pace
-
1:35
what to expect at hivr4p // virtual
-
3:35
resistance to hiv aids medicines in africa
-
12:31
an hiv vaccine: mapping uncharted territory
-
4:43
dr anthony fauci speaks to the likelihood of vaccines for hiv and covid-19
-
8:45
prep and hiv in india
-
7:32
fauci: countless lives have been saved, but an hiv vaccine and cure remain elusive